top of page
Render with background blurred_edited.jpg
Screenshot 2026-09-18 120613.png

The right vein, first time, every time.
For every clinician.

Placing an IV is the most common procedure in medicine. It's also one of the most likely to fail. That is why VeinTech have built Felix.

 

Felix takes the guess work out of vascular access, helping any clinician get it right the first time.

THE PROBLEM

Vascular access looks routine. It rarely is.

The vein a clinician can see or feel isn't always the vein worth using. Depth, size and condition all matter, and none of them are obvious from the outside.​  Pick the wrong vessel or site, and the line fails. The patient is the one left holding the outcome.

Repeated needlesticks

More misses mean more needles, more often.

Pain and anxiety

Every failed attempt adds distress, especially for children, cancer and elderly patients.

Lines that fail early

Many IVs stop working before treatment is even finished.

Delayed treatment

A line that won't go in holds up the care that depends on it.

Escalation

Difficult sticks get bumped to specialists - if one is availalble.

Avoidable cost

Every complication adds cost the hospital never needed to spend.

THE SOLUTION

Introducing Felix

Ultrasound-guided vascular access. Radically simple.

Felix is a handheld ultrasound that helps any clinician locate the strongest vein, confirm the site is worth using, and guide the needle in accurately during peripheral intravenous cannulation (PIVC).

Felix ensures that the line goes in first time, and lasts for the duration of treatment. 

1

Find

See veins in real time, including the ones you can't see or feel.

2

Assess

Check depth, size and quality before you commit.

3

Select

Choose a higher-quality vein and site, with confidence.

4

Guide

Align the cannula with the LED light for an accurate insertion.

Felix on Stand - High Resolution_edited_

CLINICAL EVIDENCE

Patient-centred innovation. Backed by science.

Felix has been shaped by the clinicians who use it every day, tested through peer-reviewed research, and protected by a growing body of original engineering.

400+
CLINICIANS CONSULTED

Throughout design and testing

3
PEER-REVIEWED PUBLICATIONS

Alongside 15+ conference abstracts

6
PATENT FAMILIES

Across the core Felix platform

ABOUT VEINTECH

Australian-founded. Built for global healthcare.

VeinTech is a Western-Australian based MedTech company on a mission to make simple procedures simple, starting with the most common invasive medical  procedure on the planet.

PERTH, AUSTRALIA

_edited_edited.jpg

Research 

Product development 

Engineering 

Company headquarters

PROVIDENCE, USA

Providence, Rhode Island_edited.jpg
Providence, Rhode Island_edited_edited_e

US operations

Clinical partnerships

Commercialisation 

Market deployment

From Western Australia to Rhode Island, VeinTech is building the clinical, regulatory and commercial infrastructure to bring new vascular access technology to healthcare. 

GET INVOLVED

Wherever you sit, there's a way in.

HOSPITALS & CLINICAL SITES

Become a pilot site

We're selecting hospitals and clinical sites to pilot Felix ahead of wider rollout. If your team wants early access, register your interest below.

Cannulation Study Kick-off FSH.HEIC

RECOGNISED IN AND SUPPORTED BY 

bottom of page